Dihydroergotamine is used to treat migraine headaches and cluster headaches. It is not recommended for migraines that affect only one side of the brain (hemiplegic migraine) or the base of the brain/neck area (basilar migraine), or to prevent migraines from occurring.
Dihydroergotamine is an ergot medication that helps narrow widened blood vessels in the head, thereby reducing the throbbing effects of these...
Read morePhase III clinical trials for Levadex, a new Migraine abortive medication are progressing well. Levadex, from MAP Pharmaceuticals, has... Read more »
As Migrainuers, we're always looking for better abortive medications to stop Migraines and their associated symptoms in their tracks. The... Read more »
MAP Pharmaceuticals recently completed patient enrollment in the efficacy (effectiveness) part of its initial Phase 3 clinical trial... Read more »
Full Question: I started using Imitrex for migraines in 1992. About 2 years ago I was switched to Zolmitriptan and it worked on my... Read more »
The FDA has issued letters to eight pharmaceutical manufacturers and 12 distributors warming them to stop marketing and distributing 20... Read more »
Source: First DataBank
Generic Name: DIHYDROERGOTAMINE - NASAL Pronounced: (dye-HI-dro-er-GOT-uh-meen) Uses This medication is used to treat migraine headache attacks.... Read more »
Drugmaker MAP Pharmaceuticals says that their inhaled migraine medication Levadex met all four of the study's goals in a recent clinical trial. The... Read more »
Source: First DataBank
Generic Name: FROVATRIPTAN - ORAL Pronounced: (froh-vuh-TRIP-tan) Interactions See also Side Effects section. Your healthcare professionals (e.g.,... Read more »
Source: First DataBank
Generic Name: ALMOTRIPTAN - ORAL Pronounced: (AL-moe-TRIP-tan) Interactions See also Side Effects section. Your healthcare professionals (e.g.,... Read more »
Source: First DataBank
Generic Name: DESVENLAFAXINE SUSTAINED RELEASE - ORAL Pronounced: (des-VEN-la-FAX-een) Interactions Your doctor or pharmacist may already be aware... Read more »